| Year |
Citation |
Score |
| 2024 |
Tabari E, Lovejoy AF, Lin H, Bolen CR, Lor Saelee S, Lefkowitz JP, Kurtz DM, Bottos A, Nielsen TG, Parreira JM, Luong KT. NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL. Leukemia & Lymphoma. 1-11. PMID 38337191 DOI: 10.1080/10428194.2024.2301924 |
0.301 |
|
| 2023 |
Alig SK, Esfahani MS, Garofalo A, Li MY, Rossi C, Flerlage T, Flerlage JE, Adams R, Binkley MS, Shukla N, Jin MC, Olsen M, Telenius A, Mutter JA, Schroers-Martin JG, ... ... Kurtz DM, et al. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature. PMID 38081297 DOI: 10.1038/s41586-023-06903-x |
0.37 |
|
| 2023 |
Sworder BJ, Kurtz DM. Cell-free DNA in large B-cell lymphoma: MRD and beyond. Seminars in Hematology. PMID 37474409 DOI: 10.1053/j.seminhematol.2023.06.004 |
0.323 |
|
| 2022 |
Esfahani MS, Hamilton EG, Mehrmohamadi M, Nabet BY, Alig SK, King DA, Steen CB, Macaulay CW, Schultz A, Nesselbush MC, Soo J, Schroers-Martin JG, Chen B, Binkley MS, Stehr H, ... ... Kurtz DM, et al. Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology. PMID 35361996 DOI: 10.1038/s41587-022-01222-4 |
0.323 |
|
| 2021 |
Roschewski M, Rossi D, Kurtz DM, Alizadeh AA, Wilson WH. Circulating Tumor DNA in Lymphoma: Principles and Future Directions. Blood Cancer Discovery. 3: 5-15. PMID 35015693 DOI: 10.1158/2643-3230.BCD-21-0029 |
0.379 |
|
| 2021 |
Shah AT, Azad TD, Breese MR, Chabon JJ, Hamilton EG, Straessler K, Kurtz DM, Leung SG, Spillinger A, Liu HY, Behroozfard IH, Wittber FM, Hazard FK, Cho SJ, Daldrup-Link HE, et al. A comprehensive circulating tumor DNA assay for detection of translocation and copy number changes in pediatric sarcomas. Molecular Cancer Therapeutics. PMID 34353895 DOI: 10.1158/1535-7163.MCT-20-0987 |
0.342 |
|
| 2021 |
Kurtz DM, Soo J, Co Ting Keh L, Alig S, Chabon JJ, Sworder BJ, Schultz A, Jin MC, Scherer F, Garofalo A, Macaulay CW, Hamilton EG, Chen B, Olsen M, Schroers-Martin JG, et al. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nature Biotechnology. PMID 34294911 DOI: 10.1038/s41587-021-00981-w |
0.331 |
|
| 2021 |
Alig S, Macaulay CW, Kurtz DM, Dührsen U, Hüttmann A, Schmitz C, Jin MC, Sworder BJ, Garofalo A, Shahrokh Esfahani M, Nabet BY, Soo J, Scherer F, Craig AFM, Casasnovas O, et al. Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002573. PMID 33909455 DOI: 10.1200/JCO.20.02573 |
0.34 |
|
| 2021 |
Kurtz DM. Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma. Haematologica. 106: 5-6. PMID 33386712 DOI: 10.3324/haematol.2020.265165 |
0.35 |
|
| 2020 |
Avanzini S, Kurtz DM, Chabon JJ, Moding EJ, Hori SS, Gambhir SS, Alizadeh AA, Diehn M, Reiter JG. A mathematical model of ctDNA shedding predicts tumor detection size. Science Advances. 6. PMID 33310847 DOI: 10.1126/sciadv.abc4308 |
0.349 |
|
| 2020 |
Cirillo M, Craig AFM, Borchmann S, Kurtz DM. Liquid biopsy in lymphoma: Molecular methods and clinical applications. Cancer Treatment Reviews. 91: 102106. PMID 33049623 DOI: 10.1016/j.ctrv.2020.102106 |
0.325 |
|
| 2020 |
Steen CB, Luca B, Esfahani MS, Nabet BY, Sworder B, Farshidfar F, Kurtz D, Liu CL, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles A, Alizadeh A, Newman AM. Abstract 1557: Landscape of tumor cell states and cellular ecosystems in diffuse large B cell lymphoma Cancer Research. 80: 1557-1557. DOI: 10.1158/1538-7445.Am2020-1557 |
0.338 |
|
| 2019 |
Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, Hamilton EG, Yang YD, Lovejoy A, Newman AM, Kurtz DM, Jin M, Schroers-Martin J, Stehr H, Liu CL, et al. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology. PMID 31711920 DOI: 10.1053/J.Gastro.2019.10.039 |
0.309 |
|
| 2019 |
Soo J, Schroers-Martin J, Garofalo A, Kurtz D, D'Emilio N, Luikart H, Alizadeh A, Khush K. Early Detection of Post-Transplant Lymphoproliferative Disorder Using Circulating Tumor DNA The Journal of Heart and Lung Transplantation. 38: S12-S13. DOI: 10.1016/J.Healun.2019.01.014 |
0.346 |
|
| 2017 |
Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery. PMID 28899864 DOI: 10.1158/2159-8290.Cd-17-0716 |
0.345 |
|
| 2017 |
Scherer F, Kurtz DM, Diehn M, Alizadeh AA. High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood. PMID 28600337 DOI: 10.1182/Blood-2017-03-735639 |
0.339 |
|
| 2017 |
Chabon J, Chaudhuri A, Azad T, Kurtz D, Stehr H, Liu C, Martin JS, Merriott D, Carter J, Ayers K, Mansfield A, Jen J, Ren H, West R, Nair V, et al. MA 13.01 Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA Journal of Thoracic Oncology. 12: S1851. DOI: 10.1016/J.Jtho.2017.09.560 |
0.325 |
|
| 2016 |
Park SM, Wong DJ, Ooi CC, Kurtz DM, Vermesh O, Aalipour A, Suh S, Pian KL, Chabon JJ, Lee SH, Jamali M, Say C, Carter JN, Lee LP, Kuschner WG, et al. Molecular profiling of single circulating tumor cells from lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America. PMID 27956614 DOI: 10.1073/Pnas.1608461113 |
0.371 |
|
| 2016 |
Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Science Translational Medicine. 8: 364ra155. PMID 27831904 DOI: 10.1126/Scitranslmed.Aai8545 |
0.405 |
|
| 2016 |
Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nature Biotechnology. PMID 27018799 DOI: 10.1038/Nbt.3520 |
0.351 |
|
| 2014 |
Kurtz DM, Gambhir SS. Tracking cellular and immune therapies in cancer. Advances in Cancer Research. 124: 257-96. PMID 25287692 DOI: 10.1016/B978-0-12-411638-2.00008-2 |
0.303 |
|
| Show low-probability matches. |